Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Impact · against what's priced in

The announcement of a lead plaintiff deadline for a securities fraud lawsuit is not a new catalyst, as the underlying failures of the Novum LVP and the resulting stock crash occurred months prior. This news simply confirms the ongoing legal overhang and regulatory distress Baxter is currently navigating.

BAX−0.10: No priced-in read yet

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

What matters in this story

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

What matters in this story

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

How each ticker is affected

Track these names every morning.

CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

ISRG Agrees to $450M Settlement: What Does It Mean for Investors?

Kaplan Fox Announces the Lead Plaintiff Deadline of December 14, 2026 in the Securities Class Action Against Gildan Activewear Inc. (GIL)

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

What matters in this story

Next reads from the same story arc

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

Deadline Alert: Baxter International, Inc. (BAX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

What matters in this story

Next reads from the same story arc

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ClearPoint Neuro, Inc. - CLPT

How each ticker is affected

Track these names every morning.

CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates

Here's Why You Should Retain CONMED Stock in Your Portfolio for Now

ISRG Agrees to $450M Settlement: What Does It Mean for Investors?

Kaplan Fox Announces the Lead Plaintiff Deadline of December 14, 2026 in the Securities Class Action Against Gildan Activewear Inc. (GIL)